Article
The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases.
Biochimica et biophysica acta - 11 Nov 2002
Kallen Karl-Josef
Abstract excerpt
The activation of cells that do not express the membrane bound interleukin-6 6 receptor (IL-6R) by IL-6 and the soluble IL-6 receptor (sIL-6R) is termed transsignalling. Transsignalling may be an pathogenetic factor in human diseases as diverse as multiple myeloma (MM), Castleman's disease, prostate carcinoma, Crohn's disease, systemic sclerosis, Still's disease, osteoporosis and cardiovascular diseases. IL-6 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
